Accelerating Digitalization in Healthcare with the InSilicoTrials Cloud-Based Platform: Four Use Cases

Area of Science:

• Computational biology
• Medical device engineering
• Pharmacology

Background:

• In silico trials are emerging as a key component in medical product development and regulatory assessment.
• Computational approaches offer advantages in testing drug candidates and medical devices, potentially reducing reliance on traditional experimental methods.

Purpose of the Study:

• To demonstrate the utility of the InSilicoTrials.com platform through diverse use cases.
• To showcase how in silico methods can enhance preclinical and clinical evaluation processes.

Main Methods:

• Utilizing a cloud-based platform hosting healthcare simulation tools for various evaluations.
• Applying in silico approaches for drug-induced cardiotoxicity risk assessment.
• Reproducing bench tests for transcatheter heart valve safety evaluation.
• Generating virtual patients for treatment effect analysis in multiple sclerosis and prostate cancer.

Main Results:

• In silico methods can improve early preclinical assessment of drug-induced cardiotoxicity.
• Virtual reproduction of bench tests enables safety assessment of medical devices like transcatheter heart valves.
• Virtual patient models facilitate evaluation of treatment effects for complex diseases.

Conclusions:

• The InSilicoTrials.com platform effectively supports diverse in silico trial applications.
• In silico trials present a viable strategy to refine, reduce, or replace traditional experimental studies in medical product development.
• This technology holds significant potential for advancing healthcare simulations across various disease areas.